The Fertility Show, Manchester Central, 24-25 March 2018
Page URL:

Think tank tells NHS: prepare for the genetic revolution

31 October 2011
Appeared in BioNews 631

The NHS must take steps to prepare for a revolution in genetics-based medicine, according to a new report by the independent think tank, the Foundation for Genomics and Public Health (the PHG Foundation). The Foundation says that rapid advances in technology will soon make it possible for individuals to have their entire genome analysed affordably, and this will have a major impact on many aspects of healthcare.

A genome is the entire genetic information possessed by an individual organism. In humans this consists of around 23,000 genes, and three billion 'letters' of DNA code. The sequence of letters in this code is unique for every single person (with the exception of identical twins, who have the same code). Whole genome sequencing (WGS) technology 'reads' an individual's complete code and so provides information about every gene that person carries. The PHG Foundation believe WGS technology will soon be so cheap and rapid to perform that it may replace conventional genetic testing, which looks at just one or a handful of genes at a time to investigate a specific disease or condition.

In a 185-page report, 'Next steps in the sequence: the implications of whole genome sequencing for health in the UK', presented to the Government's advisory body the Human Genome Strategy Group (HGSG), the PHG Foundation made recommendations to help the NHS prepare for the impending medical impact of WGS. These included creating new biomedical informatics expertise within the NHS and establishing databases to aid understanding of which genomic variants affect health. The report's lead author Dr Caroline White told the BBC: 'The biggest challenge, in a way, is interpretation [...] Once you've got your three or six billion letters of code, finding the answer in that is going to be very difficult'.

The most immediate benefits of WGS will likely be for the diagnosis, understanding and treatment of rare inherited disorders and cancer. However, in the long term, WGS has the scope to provide information on genetic predispositions to an enormous array of conditions, and even to predict the likely response of a person or their illness to particular drugs. James Peach, Director of Stratified Medicine at Cancer Research UK commented: 'We're only scratching the surface of what WGS technology can do for us [...] but there are problems about using it in the NHS, and the biggest problem is that we don't know what to do with it'.

The report is the result of a review of WGS technology by a panel of experts and industry representatives from the UK and Europe. In addition to reviewing advances in technology, they considered the ethical, social, legal and economic impact of WGS and made recommendations for the framework in which it should be used. These included developing targeted analysis techniques to minimise incidental findings; only telling patients about medically important information that arises; and providing education in genomic data interpretation for healthcare professionals.

NHS must prepare for the genetic revolution, report says
BBC News |  25 October 2011
Whole genome sequencing in health services
PHG Foundation |  25 October 2011
25 March 2013 - by Nina Chohan 
The American College of Medical Genetics and Genomics has published a report recommending that patients who have their genomes sequenced should automatically be told of incidental genetic findings....
12 March 2012 - by Dr Rebecca Hill 
Genome sequencing for all, the abuse of stored genetic data and red tape halting research are just some of the issues the NHS will have to deal with this year, according to Sir John Burn, professor of clinical genetics at the University of Newcastle, chair of the British Society for Human Genetics (BSHG)...
20 February 2012 - by Ayesha Jadoon 
With clear and concise information, the 'Genes and Life' DVD serves its purpose as an introduction to the field of genetics. However, it quickly became quite repetitive and lacked the entertainment value that would have taken it beyond merely an educational DVD...
6 February 2012 - by Dr Stuart Hogarth and Professor Paul Martin 
'Building on our inheritance: Genomic technology in healthcare' is the latest in a long line of reports that have sought to assess the potential of genomic medicine and to outline how policy can best support its development....
31 January 2012 - by Dr Linda Wijlaars 
Genomic medicine will be at the forefront of the NHS, according to a report released last week by the Human Genomics Strategy Group (HGSG). The report highlights the UK's achievements in genomic technology to date and makes six recommendations to ensure future benefit of genomic innovation within the NHS...
12 December 2011 - by Mehmet Fidanboylu 
The National Institutes of Health (NIH) in the US has demonstrated its intent to make personalised medicine a reality by outlining plans for projects set to cost almost half a billion US dollars...
28 November 2011 - by Dr Rosie Gilchrist 
An initiative has been launched to collect genetic data from NHS cancer patients in the hope of developing new, personalised treatments....
12 September 2011 - by Dr Zara Mahmoud 
Using nurses to pre-screen people for genetic risk of cancer, cardiac or endocrine disease before they're sent to specialist services can reduce referrals by up to 75 percent, a preliminary trial has found....
8 August 2011 - by Dr Kimberley Bryon-Dodd 
The NHS is 'unprepared' to deal with personalised medicine in the clinic, according to Sir John Bell - the UK Government's chief genetics advisor - during an interview with the Times. His comments come as a four-year-old girl last week became Britain's first person to have a rare genetic disease identified through DNA sequencing...
24 May 2010 - by Dr Philippa Brice 
The 2008 'House of Lords Science and Technology Committee Report' on Genomic Medicine failed to adequately reflect the realities of genomics and health, according to a new report released on 18th May 2010...
3 August 2009 - by Adam Fletcher 
The UK's Department of Health is to invest £4.5 million into a new scheme aimed at improving NHS scientists' training in genetics. By giving scientists a ‘broader' schooling, they will be better placed to advise doctors on which DNA tests might be suitable, and what to make of the results. Part of the process may include sitting in on doctor-patient consultations....
27 April 2009 - by David McDermott 
Upon collecting a prescription from my local pharmacy, I was surprised to be handed a key ring with a small plastic toilet attached (1). The NHS bowel cancer screening programme promotion is, apparently, all about toilets! It is time to ask the members of the NHS Committee, who gave their...
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.